vs
Side-by-side financial comparison of Amplify Energy Corp. (AMPY) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $56.6M, roughly 1.2× Amplify Energy Corp.). Amplify Energy Corp. runs the higher net margin — 113.9% vs -49.0%, a 162.9% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -18.1%).
Amplify Energy Corp is a crude oil company based in Houston, Texas, USA. The company was founded in 2017, and is traded on the New York Stock Exchange.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
AMPY vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.6M | $70.6M |
| Net Profit | $64.4M | $-34.6M |
| Gross Margin | 93.7% | — |
| Operating Margin | — | -56.7% |
| Net Margin | 113.9% | -49.0% |
| Revenue YoY | -18.1% | 81958.1% |
| Net Profit YoY | 967.0% | 54.9% |
| EPS (diluted) | $1.55 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.6M | — | ||
| Q3 25 | $66.4M | $70.6M | ||
| Q2 25 | $68.4M | — | ||
| Q1 25 | $72.0M | — | ||
| Q4 24 | $69.0M | — | ||
| Q3 24 | $69.9M | — | ||
| Q2 24 | $79.5M | — | ||
| Q1 24 | $76.3M | — |
| Q4 25 | $64.4M | — | ||
| Q3 25 | $-21.0M | $-34.6M | ||
| Q2 25 | $6.4M | — | ||
| Q1 25 | $-5.9M | — | ||
| Q4 24 | $-7.4M | — | ||
| Q3 24 | $22.7M | — | ||
| Q2 24 | $7.1M | — | ||
| Q1 24 | $-9.4M | — |
| Q4 25 | 93.7% | — | ||
| Q3 25 | 92.1% | — | ||
| Q2 25 | 93.1% | — | ||
| Q1 25 | 94.1% | — | ||
| Q4 24 | 93.5% | — | ||
| Q3 24 | 93.9% | — | ||
| Q2 24 | 93.8% | — | ||
| Q1 24 | 93.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | -39.9% | -56.7% | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | -5.5% | — | ||
| Q4 24 | -9.6% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 17.0% | — | ||
| Q1 24 | -11.9% | — |
| Q4 25 | 113.9% | — | ||
| Q3 25 | -31.6% | -49.0% | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | -8.1% | — | ||
| Q4 24 | -10.8% | — | ||
| Q3 24 | 32.4% | — | ||
| Q2 24 | 9.0% | — | ||
| Q1 24 | -12.3% | — |
| Q4 25 | $1.55 | — | ||
| Q3 25 | $-0.52 | — | ||
| Q2 25 | $0.15 | — | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | $-0.16 | — | ||
| Q3 24 | $0.54 | — | ||
| Q2 24 | $0.17 | — | ||
| Q1 24 | $-0.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.7M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $458.7M | $503.0M |
| Total Assets | $600.9M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.7M | — | ||
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $502.0K | — | ||
| Q1 24 | $3.0M | — |
| Q4 25 | $458.7M | — | ||
| Q3 25 | $393.0M | $503.0M | ||
| Q2 25 | $411.3M | — | ||
| Q1 25 | $402.9M | — | ||
| Q4 24 | $408.9M | — | ||
| Q3 24 | $414.7M | — | ||
| Q2 24 | $390.3M | — | ||
| Q1 24 | $381.0M | — |
| Q4 25 | $600.9M | — | ||
| Q3 25 | $731.4M | $577.1M | ||
| Q2 25 | $771.3M | — | ||
| Q1 25 | $753.6M | — | ||
| Q4 24 | $747.1M | — | ||
| Q3 24 | $739.2M | — | ||
| Q2 24 | $720.4M | — | ||
| Q1 24 | $712.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.4M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | -0.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-13.4M | — | ||
| Q3 25 | $13.4M | $-84.6M | ||
| Q2 25 | $23.7M | — | ||
| Q1 25 | $25.5M | — | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $15.7M | — | ||
| Q2 24 | $15.4M | — | ||
| Q1 24 | $7.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.71× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMPY
| Oil And Gas | $54.7M | 97% |
| Other | $1.8M | 3% |
VRDN
Segment breakdown not available.
